EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives

Chin-Ling Li iD, Shih-Feng Liu

International Journal of Molecular Sciences · 04.07.2024 · 25 (13) · 7347

DOI: 10.3390/ijms25137347 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.07.2024. Verfasst von Chin-Ling Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Biomarkers. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic obstructive pulmonary disease (COPD) plays a significant role in global morbidity and mortality rates, typified by progressive airflow restriction and lingering respiratory symptoms. Recent explorations in molecular biology have illuminated the complex mechanisms underpinning COPD pathogenesis, providing critical insights into disease progression, exacerbations, and potential therapeutic interventions. This review delivers a thorough examination of the latest progress in molecular research related to COPD, involving fundamental molecular pathways, biomarkers, therapeutic targets, and cutting-edge technologies. Key areas of focus include the roles of inflammation, oxidative stress, and protease–antiprotease imbalances, alongside genetic and epigenetic factors contributing to COPD susceptibility and heterogeneity. Additionally, advancements in omics technologies—such as genomics, transcriptomics, proteomics, and metabolomics—offer new avenues for comprehensive molecular profiling, aiding in the discovery of novel biomarkers and therapeutic targets. Comprehending the molecular foundation of COPD carries substantial potential for the creation of tailored treatment strategies and the enhancement of patient outcomes. By integrating molecular insights into clinical practice, there is a promising pathway towards personalized medicine approaches that can improve the diagnosis, treatment, and overall management of COPD, ultimately reducing its global burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveBiomarkersHumansOxidative StressProteomicsGenomicsMetabolomicsEpigenesis, Genetic

Stichwörter der Autor:innen

chronic obstructive pulmonary diseaseepigenetics and gene regulationmolecular biomarkersmolecular pathogenesisprecision medicinetargeted therapies

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
  • College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.

ORCID-Profile: Chin-Ling Li

Zitieren

APA

Li, C. L., & Liu, S. F. (2024). Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives. International Journal of Molecular Sciences, 25(13), 7347. https://doi.org/10.3390/ijms25137347

Vancouver

Li CL, Liu SF. Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives. International Journal of Molecular Sciences. 2024;25(13):7347. doi:10.3390/ijms25137347

BibTeX
@article{Li2024,
  author = {Li, Chin-Ling and Liu, Shih-Feng},
  title = {Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {13},
  pages = {7347},
  doi = {10.3390/ijms25137347}
}
Kostenlos starten →